PTC Therapeutics Director Michael Schmertzler sells 24,000 shares for $1.73 million

• PTC Therapeutics director Michael Schmertzler disclosed sales of 24,000 common shares on Aug. 19-20.
• Transactions priced between USD 70.78 and USD 73.67 per share.
• Indirect stake reported at 1,361,594 shares following the sales.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PTC Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001288952-26-000004), on August 21, 2026, and is solely responsible for the information contained therein.